Form 8-K - Current report:
SEC Accession No. 0001659617-18-000002
Filing Date
2018-02-07
Accepted
2018-02-07 09:26:48
Documents
3
Period of Report
2018-02-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-kwp1122.htm 8-K 15678
2 EXHIBIT 99.1 exh991-wp1122.htm EX-99.1 9397
3 moleculinlogoa02.jpg GRAPHIC 11658
  Complete submission text file 0001659617-18-000002.txt   42309
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 18579460
SIC: 2834 Pharmaceutical Preparations